Results from the ESADA study.

The guidelines provide suggested strategies for the prevention, detection and treatment of cardiotoxicity.

Survival rates for out-of-hospital cardiac arrest patients also increased significantly.

A prospective population-based cohort study involving 1880 patients.

Results from a randomised controlled trial.

Large study indicates widening health gap between the richest and poorest in the UK population.

Only 3%, primarily older patients, experience any cardiac event during treatment.

Two-thirds of the invited individuals accepted the screening invitations.

Results from a population-based cohort study using data from the UK biobank.

Results from a large observational study.

Analysis of the PARADIGM-HF and ATMOSPHERE trials.

SEER analysis of 15,500 patients finds about a 15% increase in risk from nonadherence.

The findings suggest efforts to modify cancer therapies in children and promote health surveillance are showing benefits.

Results from the combined data of SUSTAIN 6 and PIONEER 6 study.